Sunday, March 10 (11)

11 am–Noon

Neuropathic Pain Pharmacologic Management: Maximizing Success with Available Agents and Emerging Therapies (411) Featured

Efficacy is often limited with currently available neuropathic pain adjuvants. This session will focus on mitigating the failure of currently available pharmacologic agents, recognizing the limitation of current neuropathic pain algorithms, understanding the role of pharmacogenomics in neuropathic pain treatment choice, and the status of novel agents in development.

Mitigating Neuropathic Pain Pharmacologic Failures

James C. Watson, MD

Emerging Therapies in the Treatment of Neuropathic Pain

Charles E. Argoff, MD

Learning Objectives:

  • Identify common reasons patients fail first line neuropathic pain adjuvants and practical approaches to maximize the chance of success with currently available agents.
  • Examine the limitations of evidence based neuropathic pharmacologic treatment algorithms.
  • Identify where novel or re-emerging treatments fit within current evidence based treatment algorithms.
  • Analyze how advances in pharmacogenomics may influence neuropathic pain pharmacologic treatment choices currently and in the future.
11 am–Noon

Lumbar Medial Branch Radiofrequency Neurotomy: How Understanding Anatomy, Patient Selection, and Technique Affect Outcomes (410)

A successful outcome of lumbar medial branch radiofrequency neurotomy (LMBRFN) is dependent on careful attention to principles of facet join pain diagnosis and elements LMBRFN procedure technique. This session will present in depth discussion of these multiple, intricate factors. The relevant anatomy, diagnostic standards, and physics of radiofrequency lesions as applied to LMBRFN will be detailed, as supported by the current medical literature.

Lumbar Medial Branch Blocks to Accurately Diagnose Lumbar Zygaphophyseal Joint Pain: False Positives, Disease Prevalence, and Diagnostic Confidence

Byron Schneider, MD

Anatomy of the Lumbar Medial Branch Block and How This Relates To Ideal Procedural Technique

Zachary McCormick, MD

Evidence-Based Review of Lumbar Medial Branch Radiofrequency Neurotomy Outcomes

David J. Kennedy, MD

Learning Objectives:

  • Recognize the exact anatomy of the lumbar medial branch nerves and how they can be best accessed.
  • Define the diagnostic principles of medial branch nerve blocks and how they can be interpreted to define a 'positive' for patient selection, based on the best medical evidence.
  • Summarize the physics the lesioning the medial branch nerves via radiofrequency technology, in a manner that is most likely to achieve effective coagulation of the nerve, based on the medical literature.
9:45–10:45 am

Mobile-Assisted Treatment: Health-Tech Innovations to Enhance Pain Care and Addiction Treatment (408)

Combining Pain Treatment with Community Based Support Enhanced by Wearable Technology in Patients with Dual Diagnosis. Mobile applications hold the promise of improving chronic pain care in patients with dual diagnosis by facilitating access to resources that minimize unnecessary readmission and relapse of substance use.

Taming the Two-Headed Monster: Managing the Patient with Dual Diagnoses of Chronic Pain and Substance Use Disorder

Vitaly Gordin

Connecting the Disconnected: Online Support Networks For Addiction Recovery

Thomas Simpatico

Enhancing Hub & Spoke Medication-Assisted Treatment with Mobile Applications and Biosensors

Eric Dentler

Learning Objectives:

  • Discuss the incidence of chronic pain in patients with SUD.
  • Demonstrate the appropriate approach to pain management in this patient population.
  • Identify emerging community based approaches including wearable technologies that help monitoring these patient and potentially prevent a relapse.
9:45 am–10:45

Neuropathic Pain: Beyond Adjuvants and Opioids—A Look at New and Reemerging Treatments (407)

The Role of Low-Dose Naltrexone for the Treatment of Neuropathic Pain Syndromes

Neel D. Mehta, MD

Buprenorphine in Neuropathic Pain Treatment

James C. Watson, MD

Cancer Neuropathic Pain: What's New?

Amitabh Gulati, MD

Learning Objectives:

  • Describe the role of low dosed naltrexone in the treatment of neuropathic pain.
  • Identify novel treatments in development and emerging evidence for role of currently available or repurposed treatments in the treatment of neuropathic pain.
  • Identify where these novel or re-emerging treatments fit within current evidence based treatment algorithms.
Subscribe to this RSS feed